Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.97M Buy
16,223
+13,509
+498% +$1.77M 0.01% 729
2025
Q4
$370K Sell
2,714
-41
-1% -$5.9K ﹤0.01% 1233
2025
Q3
$406K Buy
2,755
+688
+33% +$95.4K ﹤0.01% 1148
2025
Q2
$267K Sell
2,067
-43
-2% -$5.21K ﹤0.01% 1235
2025
Q1
$252K Buy
2,110
+176
+9% +$21.8K ﹤0.01% 1169
2024
Q4
$224K Buy
1,934
+17
+0.9% +$2.15K ﹤0.01% 1162
2024
Q3
$259K Buy
1,917
+1
+0.1% +$134 ﹤0.01% 1091
2024
Q2
$260K Buy
+1,916
New +$261K ﹤0.01% 1039
2023
Q1
Sell
-2,066
Closed -$228K 1009
2022
Q4
$228K Buy
+2,066
New +$217K ﹤0.01% 816

Other funds holding XYL

Equitable Holdings's XYL Position: Q1 2026 in Review

Equitable Holdings increased its Xylem (XYL) stake by 498% in Q1 2026, buying an estimated $1.77M and bringing the position to 16,223 shares worth $1.97M. The position accounts for 0.01% of the portfolio, ranked #729.

Equitable Holdings first reported a position in XYL in Q4 2022 and has held it in 9 quarters since. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Equitable Holdings held 16,223 shares of Xylem worth $1.97M as of Q1 2026.
  • Equitable Holdings bought 13,509 Xylem shares in Q1 2026, an estimated $1.77M.
  • Xylem made up 0.01% of Equitable Holdings's portfolio in Q1 2026, its #729 holding.
  • Equitable Holdings first reported a position in Xylem in Q4 2022 and has held it in 9 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.